Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity

American Journal of Pathology

Volumn 156, Issue 6, 2000, Pages 2169-2177

  Diaz Granados, N ^a   Howe, K ^a   Lu, J ^a   McKay, D M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; MYELOPEROXIDASE; PENTOXIFYLLINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; COLITIS; CONTROLLED STUDY; DIARRHEA; ENZYME ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; ION TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0033870127     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65087-0     Document Type: Article

References (47)

1. Phosphodiesterase isozymes. Molecular targets for novel anti-asthma agents
2. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung
3. Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents
4. Phosphodiesterase (PDE) 4 inhibitors: Anti-inflammatory drugs of the future?
5. Effect of rolipram in a murine model of acute inflammation: Comparison with the corticoid dexamethasone
6. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation
7. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4
8. Suppression on TNF-α expression, inhibition of Th1 activity and amelioration of collagen-induced arthritis by rolipram
9. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
10. A novel method in induction or reliable experimental acute and chronic colitis in mice
11. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
12. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice
13. Role of interleukin-10 in murine model of dextran sulfate sodium- induced colitis
14. The efficacy of BATy1015 in dextran sulfate model of mouse colitis
15. Anti-neutrophil serum attenuates dextran sulfate-sodium-induced colonic damage in the rat
16. Neutralization of tumour necrosis factor (TNF) but not IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
17. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
18. Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice
19. Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis
20. Reactivation of hapten-induced colitis and its prevention by anti- inflammatory drugs
21. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease
22. Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen (YPM)
23. + T cells mediate superantigen-induced abnormalities in murine jejunal ion transport
24. 2
25. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
26. Effect of acute pentoxifylline treatment in an experimental model of colitis
27. Treatment of Crohn's disease with pentoxifylline: Lack of correlation between clinical improvement and mucosal cytokine levels
28. Combination therapy of pentoxifylline and TNFα monoclonal antibody in dextran sulfate-induced mouse colitis
29. Influence of topical rectal application of drugs on dextran sulfate- induced colitis in rats
30. Changes in colonic mucosal permeability in mouse colitis induced by dextran sulfate sodium
31. Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa
32. Prolonged colonic epithelial hyporesponsiveness after colitis: Role of inducible nitric oxide synthase
33. Ion transport in normal and inflamed human jejunum in vitro: Changes with electrical field stimulation and theophylline
34. Mast cell mediated ion transport in the intestine from patients with and without inflammatory bowel disease
35. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
36. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice
37. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
38. +-cell depleted, athymic and NK-cell depleted SClD mice
39. Proliferative effect of dextran sulfate sodium (DSS)-pulsed macrophages on T cells from mice with DSS-induced colitis and inhibition of effect by IgG
40. Induction of intestinal tumors in rats by dextran sulfate sodium
41. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes
42. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice
43. Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNFα release
44. Pentoxifylline in vivo down regulates the release of IL-1β, IL-6, IL- 8 and tumour necrosis factor-α by human peripheral blood mononuclear cells
45. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: Synergism with prostanoids and salbutamol
46. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent
47. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: In vitro anti-inflammatory actions